S2R
0.13
38.3%
XGLR
0.004
-42.9%
4DX
0.775
36%
ALM
0.005
-28.6%
8CO
0.035
34.6%
MEM
0.003
-25%
AUK
0.004
33.3%
TYX
0.003
-25%
AYT
0.004
33.3%
OMG
0.011
-21.4%
BLU
0.008
33.3%
OEL
0.004
-20%
DRE
0.016
33.3%
PKD
0.028
-17.6%
FRX
0.008
33.3%
BRU
0.02
-16.7%
JAL
0.12
30.4%
ETM
0.07
-16.7%
ILT
0.275
27.9%
OSX
0.01
-16.7%
AHK
0.435
26.1%
TAR
0.01
-16.7%
RUL
4.63
22.8%
IFG
0.031
-16.2%
AGD
0.049
22.5%
DEL
0.13
-16.1%
AZI
0.023
21.1%
TG1
0.028
-15.2%
DAL
0.047
20.5%
AVE
0.006
-14.3%
AHN
0.006
20%
AZL
0.006
-14.3%
AKN
0.006
20%
ENV
0.006
-14.3%
ARV
0.006
20%
LCL
0.006
-14.3%
KAL
0.048
20%
SPX
0.006
-14.3%
RRR
0.096
20%
VHL
0.025
-13.8%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CMP FDA clearance

Compumedics (ASX:CMP) announces the US FDA has cleared the Somfit device to be marketed in the USA. This marks the achievement of another significant strategic milestone for the Somfit technology platform in one of the world’s largest sleep markets https://www.compumedics.com.au/en/asx-announcements/somfit-update2-2/ #shorts